Back to Results
First PageMeta Content



A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer 1Hidalgo Patient Demographics (n=47) DEM + GEM
Add to Reading List

Document Date: 2014-09-25 16:14:56


Open Document

File Size: 397,60 KB

Share Result on Facebook